Skip to Main Content (Press Enter)

Logo UNIMI
  • ×
  • Home
  • Persone
  • Attività
  • Ambiti
  • Strutture
  • Pubblicazioni
  • Terza Missione

Expertise & Skills
Logo UNIMI

|

Expertise & Skills

unimi.it
  • ×
  • Home
  • Persone
  • Attività
  • Ambiti
  • Strutture
  • Pubblicazioni
  • Terza Missione
  1. Pubblicazioni

Transcranial direct current stimulation (tDCS) in unipolar vs. bipolar depressive disorder

Articolo
Data di Pubblicazione:
2011
Citazione:
Transcranial direct current stimulation (tDCS) in unipolar vs. bipolar depressive disorder / A. Brunoni, R. Ferrucci, M. Bortolomasi, M. Vergari, L. Tadini, P.S. Boggio, M. Giacopuzzi, S. Barbieri, A. Priori. - In: PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY. - ISSN 0278-5846. - 35:1(2011), pp. 96-101. [10.1016/j.pnpbp.2010.09.010]
Abstract:
Transcranial direct current stimulation (tDCS) is a non-invasive method for brain stimulation. Although pilot trials have shown that tDCS yields promising results for major depressive disorder (MDD), its efficacy for bipolar depressive disorder (BDD), a condition with high prevalence and poor treatment outcomes, is unknown. In a previous study we explored the effectiveness of tDCS for MDD. Here, we expanded our research, recruiting patients with MDD and BDD. We enrolled 31 hospitalized patients (24 women) aged 30-70. years 17 with MDD and 14 with BDD (n = 14). All patients received stable drug regimens for at least two weeks before enrollment and drug dosages remained unchanged throughout the study. We applied tDCS over the dorsolateral prefrontal cortex (anodal electrode on the left and cathodal on the right) using a 2. mA-current for 20. min, twice-daily, for 5 consecutive days. Depression was measured at baseline, after 5 tDCS sessions, one week later, and one month after treatment onset. We used the scales of Beck (BDI) and Hamilton-21 items (HDRS). All patients tolerated treatment well without adverse effects. After the fifth tDCS session, depressive symptoms in both study groups diminished, and the beneficial effect persisted at one week and one month. In conclusion, our preliminary study suggests that tDCS is a promising treatment for patients with MDD and BDD.2.
Tipologia IRIS:
01 - Articolo su periodico
Elenco autori:
A. Brunoni, R. Ferrucci, M. Bortolomasi, M. Vergari, L. Tadini, P.S. Boggio, M. Giacopuzzi, S. Barbieri, A. Priori
Autori di Ateneo:
FERRUCCI ROBERTA ( autore )
PRIORI ALBERTO ( autore )
Link alla scheda completa:
https://air.unimi.it/handle/2434/168708
  • Aree Di Ricerca

Aree Di Ricerca

Settori


Settore MED/26 - Neurologia
  • Informazioni
  • Assistenza
  • Accessibilità
  • Privacy
  • Utilizzo dei cookie
  • Note legali

Realizzato con VIVO | Progettato da Cineca | 26.6.0.0